Berkshire shareholders head to Greg Abel’s first annual meeting, with Buffett in audience

Berkshire Hathaway faces a leadership transition as Greg Abel prepares for his first annual meeting, with shareholders focused on the conglomerate’s $373 billion cash pile, recent stock buybacks resumed in March, and how it will allocate capital going forward. The company is expected to report several billion dollars of operating profit, but operating profit fell 6% in 2025 and revenue growth has been nonexistent, underscoring sluggish fundamentals. Investors will also watch for updates on its nearly $300 billion equity portfolio, governance proposals, and exposure to softer consumer demand amid higher inflation and AI-driven market shifts.

Analysis

The market is treating this as a governance-and-capital-allocation reset, not a fundamental inflection. That matters because Berkshire’s discount to the market has been driven less by operational decay than by a credibility gap around whether its capital can still compound faster than buybacks and Treasury bills; the first real test is whether Greg Abel can convince investors that Berkshire’s cash stack is an asset, not dead weight. If he signals a more aggressive repurchase posture or a willingness to lean harder into higher-beta deployments, the stock can re-rate mechanically even without improving near-term operating trends.

The second-order issue is portfolio stewardship. Abel’s lack of a public stock-picking track record raises the probability that Berkshire’s equity book becomes more conservative and more index-like, which would reduce the embedded “Buffett premium” over time. That is bearish for the class of long-duration compounding names that have historically benefited from Berkshire as a patient capital provider, but it may also force a market cleanup: if Berkshire is no longer a hidden anchor buyer, some mega-cap quality names could see less passive support on drawdowns.

On the operating side, this is a late-cycle demand check rather than a crisis. Berkshire’s mix of rail, consumer, and industrial exposure makes it an unusually clean read on U.S. nominal growth; if management sounds cautious on volumes and pricing, that would be a warning that the market’s AI-led capex exuberance is not yet filtering into the real economy. The key contrarian point is that expectations are already low enough that merely competent communication can outperform — the stock does not need a visionary pivot to work, only evidence that capital allocation can be slightly more aggressive and that the franchise still deserves a conglomerate premium.

Key Decisions for Investors

• Long BRK.B on weakness into the meeting, 1-3 month horizon: position for a 5-8% relief rally if Abel validates buybacks and capital discipline; trim if the stock fails to hold relative strength versus the S&P 500 after the event.
• Buy BRK.B call spreads 2-4 months out rather than stock if implied volatility is reasonable: upside is tied to a sentiment reset, while downside is limited if the meeting is merely incremental.
• Pair trade: long BRK.B / short QQQ for 4-8 weeks as a governance vs. momentum reversion trade; thesis is that any modestly constructive Abel messaging can close part of the valuation gap while AI names remain vulnerable to execution disappointment.
• Short-duration hedge: buy puts or short rail/consumer cyclical proxies if Berkshire sounds cautious on demand; the best read-through is to economically sensitive names with exposure to U.S. freight and discretionary spending over the next 1-2 quarters.
• Reduce exposure to names that rely on Berkshire-style patient capital support if Berkshire signals a more passive capital posture; the risk is a lower marginal bid for large-cap quality drawdowns over the next 6-12 months.